Botulinum toxin A is an effective therapeutic tool for the management of parotid sialocele and fistula: A systematic review
- PMID: 32128429
- PMCID: PMC7042652
- DOI: 10.1002/lio2.350
Botulinum toxin A is an effective therapeutic tool for the management of parotid sialocele and fistula: A systematic review
Abstract
Objectives: In the management of parotid sialocele and fistula, various conservative and surgical methods have been described. Some studies have described the use of Botulinum toxin A (Botox A) for the management of parotid sialocele and fistula. This is a less invasive and potentially equally effective option. We therefore conducted a systematic review on the current body of literature relating to this specific use of Botox A.
Methods: A search strategy was conducted in July 2019 using the following electronic databases: Cochrane Database of Systematic Reviews, EMBASE, Google Scholar, PubMed, Scopus, and Web of Science. A search of all articles from inception until 31 August 2019 was performed.
Results: Literature searches of electronic databases identified 67 articles eligible for review, of which 15 fulfilled all criteria. These studies were small and in total only 47 patients were included. The majority of sialoceles and fistulas presented as a complication of surgery (77%) with the remaining cases occurring as a result of trauma. The typical age at presentation was between 32 and 88 years of age (mean age of 52 years). All patients were initially treated with and failed other conservative measures. Botox A injection was considered as a final conservative treatment option. The toxin was administered percutaneously in all cases of parotid sialocele and fistula. Dosage of Botox ranged from 10 to 200 units with majority of patients (58%) requiring only one injection. The overall success rate for patients treated with Botox A injections ranged between 70 and 100% for parotid sialoceles and fistulas.
Conclusion: Botox A injections are successful in the treatment of parotid sialoceles and fistulas and should be considered before the use of invasive conventional options. Further studies with larger numbers are needed to ratify this recommendation. Success rate for patients, treated with Botox A injection was between 70 and 100% for parotid sialocele and fistula. Patients who failed initial treatment with Botox A were re-administered with Botox A and eventually resolved.
Keywords: Botox A; botulinum toxin A; parotid fistula; parotid sialocele.
© 2020 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals, Inc. on behalf of The Triological Society.
Conflict of interest statement
The authors declare no potential conflict of interests.
Similar articles
-
Botulinum toxin A for the treatment of first bite syndrome-a systematic review.Gland Surg. 2022 Jul;11(7):1251-1263. doi: 10.21037/gs-22-112. Gland Surg. 2022. PMID: 35935568 Free PMC article. Review.
-
Use of Botox (OnabotulinumtoxinA) for the Treatment of Parotid Sialocele and Fistula After Extirpation of Buccal Squamous Cell Carcinoma With Immediate Reconstruction Using Microvascular Free Flap: A Report of 3 Cases.J Oral Maxillofac Surg. 2016 Aug;74(8):1678-86. doi: 10.1016/j.joms.2016.01.038. Epub 2016 Jan 29. J Oral Maxillofac Surg. 2016. PMID: 26902710
-
[Injection of incobotulinum toxin A for the prevention of postoperative salivary fistula and sialocele].Stomatologiia (Mosk). 2021;100(2):55-59. doi: 10.17116/stomat202110002155. Stomatologiia (Mosk). 2021. PMID: 33874662 Russian.
-
Update: Prevention and Treatment of Parotid/Submandibular Gland Fistula/Sialocele Following Rhytidectomy With Botulinum Toxin A.Aesthet Surg J. 2025 Jan 16;45(2):113-116. doi: 10.1093/asj/sjae190. Aesthet Surg J. 2025. PMID: 39224090 Review.
-
Extracapsular dissection by the sternocleidomastoid muscle-parotid space approach reduces the risks of postparotidectomy sialocele and salivary fistula.Head Neck. 2022 Nov;44(11):2522-2527. doi: 10.1002/hed.27159. Epub 2022 Aug 1. Head Neck. 2022. PMID: 35912938
Cited by
-
The role of Botulinum Toxin for the Management of post Parotidectomy Sialocele: A Randomized Controlled Trial.Indian J Otolaryngol Head Neck Surg. 2025 Mar;77(3):1215-1219. doi: 10.1007/s12070-024-05226-1. Epub 2025 Jan 16. Indian J Otolaryngol Head Neck Surg. 2025. PMID: 40093478
-
Botulinum toxin A for the treatment of first bite syndrome-a systematic review.Gland Surg. 2022 Jul;11(7):1251-1263. doi: 10.21037/gs-22-112. Gland Surg. 2022. PMID: 35935568 Free PMC article. Review.
-
The Management of Salivary Fistulas.Semin Plast Surg. 2022 Dec 3;37(1):4-8. doi: 10.1055/s-0042-1759561. eCollection 2023 Feb. Semin Plast Surg. 2022. PMID: 36776805 Free PMC article. Review.
-
Partial Submandibular Gland Resection With Ultrasonic Dissector vs Electrocautery.Aesthet Surg J Open Forum. 2025 Feb 11;7:ojaf011. doi: 10.1093/asjof/ojaf011. eCollection 2025. Aesthet Surg J Open Forum. 2025. PMID: 40236889 Free PMC article.
-
Guidelines for the Use of Botulinum Toxin in Otolaryngology From the Korean Society of Laryngology, Phoniatrics and Logopedics Guideline Task Force.Clin Exp Otorhinolaryngol. 2023 Nov;16(4):291-307. doi: 10.21053/ceo.2023.00458. Epub 2023 Oct 25. Clin Exp Otorhinolaryngol. 2023. PMID: 37905325 Free PMC article.
References
-
- Iyengar AR, Tanwar R, Nagesh KS, Patil S, Divyalakshmi MR, Rao G. Traumatic sialocele of parotid duct: report of a case with review of literature. J Indian Acad Oral Med Radiol. 2010;22(3):171‐173.
-
- Darwish HS, Satti KS. Post‐traumatic right parotid sialocele review of literature with report of a case. JSM Clin Med Imaging Cases Rev. 2016;1(1):1001.
Publication types
LinkOut - more resources
Full Text Sources